Covering Coronavirus Test Act of 2020

Bill: 116-hr-6173
Sponsor: full_name: Rep. DeGette, Diana [D-CO-1]
Introduced: 2020-03-10
Policy area: Health
Subjects: Cardiovascular and respiratory health

Emergency medical services and trauma care

Employee benefits and pensions

Health care costs and insurance

Health care coverage and access

Health promotion and preventive care

Infectious and parasitic diseases

Medical tests and diagnostic methods
Latest action: action_date: 2020-03-10
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2020-03-10
action_desc: Introduced in House
text: <p><b>Covering Coronavirus Test Act of 2020</b></p> <p>This bill requires health insurance plans to cover diagnostic tests for COVID-19 (i.e., coronavirus disease 2019) without imposing cost sharing. </p>

tv_txt: I 116th CONGRESS 2d Session H. R. 6173 IN THE HOUSE OF REPRESENTATIVES March 10, 2020 Ms. DeGette (for herself and Ms. Shalala ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to cover COVID–19 testing without cost sharing.

1. Short title This Act may be cited as the Covering Coronavirus Test Act of 2020 . 2. Requiring group health plans and health insurance issuers offering group or individual health insurance coverage to cover COVID–19 testing without cost sharing Section 2713 of the Public Health Service Act ( 42 U.S.C. 300gg–11 ) is amended— (1) in subsection (a)— (A) in paragraph (2), by striking and at the end; (B) in paragraph (3), by striking the period at the end and inserting a semicolon; (C) in paragraph (4), by striking the period at the end and inserting ; and ; (D) by redesignating paragraph (5) as paragraph (6); and (E) by inserting after paragraph (4) the following new paragraph: (5) any service consisting of a test furnished for purposes of diagnosing COVID–19. ; and (2) in subsection (b), by adding at the end the following new paragraph: (3) Clarification of nonapplication of interval to COVID–19 laboratory tests The interval described in paragraph (1) shall not apply to services described in subsection (a)(5). .